WCG Unveils Major Enhancements to the Industry-Leading Site Network

PRINCETON, N.J., Oct. 30, 2024 /PRNewswire/ — WCG, the global leader in providing solutions that measurably improve and accelerate clinical research, proudly announces major enhancements to its premier Site Network. As a result of substantial investments and expanded capabilities, the WCG Site Network will be the largest and most advanced traditional site network in the industry, offering unparalleled advantages for research sites and sponsors/CROs alike. A new site support team is specifically dedicated to helping network sites optimize their study performance and enrollment. This improved network empowers sites with more study opportunities, streamlined processes, and enhanced performance, while providing sponsors and CROs with faster timelines and broader participant access.

“We are deeply committed to enabling sites and studies to achieve unprecedented levels of efficiency and success, and the new enhancements to our WCG Site Network further emphasize that commitment,” said Sam Srivastava, chief executive officer, WCG. “Our goal is to accelerate the path from groundbreaking research to transformative treatment, reflecting our unwavering dedication to innovation and excellence in clinical trials.”

Value delivered from the WCG Site Network:

  • Expanded Study Opportunities: Access to 300+ study opportunities per year, ensuring a steady flow of research participation options for research sites.
  • Improved Site Performance: Average of 28% higher site performance compared to sites outside of the WCG Site Network.
  • Reduced Administrative Burden: Streamlined processes and personalized study management.
  • Enhanced Enrollment: Average of 34% increase in enrollment.
  • Extensive Network: Access to more than 470 independent site and community hospitals, and 1,000+ vetted and experienced principal investigators.
  • Accelerated Timelines: Up to 27% faster contracting timelines and an average of 29% faster study start-up timelines.

“As a trusted partner, we remain focused on supporting research sites with best-in-class resources and opportunities while also providing sponsors and CROs with a more robust, faster, and streamlined path to clinical trial success,” said Lindsay McCarthy, vice president of the WCG Site Network.

About WCG

WCG is a global leader of solutions that measurably improve and accelerate clinical research. Biopharmaceutical and medical device companies, contract research organizations (CROs), research institutions, and sites partner with us for our unmatched expertise, data intelligence, and purpose-built technology to make informed decisions and optimize study outcomes, while maintaining the highest standards of human participant protection. WCG raises the bar by pioneering new concepts, reimagining processes, fostering compliance and safety, and empowering those who perform clinical trials to accelerate the delivery of medical therapies and devices that improve lives. For more information, please visit wcgclinical.com or follow us on LinkedIn or X @WCGClinical.

View original content to download multimedia:https://www.prnewswire.com/news-releases/wcg-unveils-major-enhancements-to-the-industry-leading-site-network-302290968.html

SOURCE WCG

Staff

Recent Posts

Vent Creativity Appoints Paul Abrams as Vice President of Sales to Lead Commercial Growth

NEW YORK--(BUSINESS WIRE)--Vent Creativity, a medical technology company advancing AI-enabled surgical planning, today announced the…

14 hours ago

AEON Clinic Announces Next Generation Medicine Congress 2026 Event: A Global Convergence on Human Longevity in Dubai

AEON Clinic Elevates Dubai to Global Hub for Longevity Science, A Definitive Four-Day Summit Defining…

14 hours ago

AI-Era Position Statement to Protect the Integrity of Healthcare, Technology, and Services Benchmarking published by Black Book Research

Black Book outlines an AI-era integrity architecture for healthcare benchmarking, instrumentation hardening, tiered verification, real-time…

2 days ago

New employee representative on the Board of Directors of Novo Nordisk A/S

Bagsværd, Denmark, 31 January 2026 – Thomas Rantzau, employee representative on the Board of Directors since…

2 days ago

Embers to Empowerment: The Womb Room Reopens in Govans, Expanding Community-Centered Perinatal Care After Hampden Fire

Baltimore, Maryland, Jan. 31, 2026 (GLOBE NEWSWIRE) -- After sustaining water damage during the massive…

2 days ago

Oxford Healthspan to Introduce New Primeadine® GF Powder Through a ‘Longevity Shot’ Experience During Grammy Week in Los Angeles

Science-Backed Spermidine Ritual Brings Cellular Renewal to a High-Performance Cultural Moment Primeadine Longevity Shot Primeadine…

2 days ago